Injections for obesity

by SUSANNE DONNER

This is the breakthrough we've all been waiting for," says Matthias Tschöp. The neuroendocrinologist from the Helmholtz Zentrum München is electrified by the first generation of drugs to combat obesity. More and more overweight syringes are entering the pharmaceutical market.

For decades, pharmacies had nothing to offer against obesity. Then, in 2016, the artificial intestinal hormone liraglutide kicked off, followed in January 2022 by semaglutide. And now experts are expecting the third one shortly and with…

Read more with bdw+

now Try 1 month FREE and access
on all articles of the magazine
image of science received!

secure offer

Are you already a bdw+ subscriber? Sign up here"

Are you already a subscriber to the bdw print magazine? Upgrade here»